Patent ID: 7595394

Claim:
A compound represented by formula (A): where R1 denotes a C1-C18 alkyloxy group or a C1-C18 alkylamino group; R2 denotes a residual group after removal of an amino group and a carboxyl group from an a-amino acid selected from the group consisting of glycine, alanine, valine, leucine and isoleucine; R3 denotes a C1-C18 alkyloxy group, a C1-C18 alkylamino group, or a peptide having 2-6 α-amino acids selected from the group consisting of glycine, alanine, valine, leucine and isoleucine and having a methoxy group at the C-terminal; each R4 and each R5 denote either a methyl group, or a hydrogen atom, a vinyl group, an ethyl group, a 1-methoxyethyl group, a 1-bromoethyl group or a formyl group, wherein, where each R4 denotes a methyl group, each R5 denotes a hydrogen atom, a vinyl group, an ethyl group, a 1-methoxyethyl group, 1-bromoethyl group or a formyl group, and where each R4 denotes a hydrogen atom, a vinyl group, an ethyl group, a 1-methoxyethyl group, a 1-bromoethyl group or a formyl group, each R5 denotes a methyl group; M denotes two hydrogen atoms bonded to the two pyrrole nitrogen atoms or an ion of a transition metal belonging to the fourth to fifth periods in the Periodic Table; X— denotes a halogen ion that is present where M denotes the transition metal ion; and n which denotes the number of X is the number obtained by subtracting 2 from the valency of the transition metal ion.